Cross-border reproductive care: a phenomenon expressing the controversial aspects of reproductive technologies

Reproductive Biomedicine Online
A P FerrarettiM Cristina Magli

Abstract

Cross-border reproductive care, also called reproductive tourism, refers to the travelling of citizens from their country of residence to another country in order to receive fertility treatment through assisted reproductive technology. Several reasons account for cross-border reproductive care: (i) a certain kind of treatment is forbidden by law in the couple's own country or is inaccessible to the couple because of their demographic or social characteristics; (ii) foreign centres report higher success rates compared with those of the centres in the country of residence; (iii) a specific treatment may be locally unavailable because of a lack of expertise or because the treatment is considered experimental or insufficiently safe; and (iv) limited access to the treatment in the couple's home country because of long waiting lists, excessive distance from a centre or high costs. Although cross-border reproductive care can be viewed as a safety valve, the phenomenon is often associated with a high risk of health dangers, frustration and disparities. Solutions to these problematic effects need to be considered in the light of the fact that cross-border reproductive care is a growing phenomenon.

References

Oct 30, 2004·Human Reproduction·Guido Pennings
Nov 26, 2005·Human Reproduction·Roberto Matorras
Jun 3, 2006·Human Reproduction·Anna Pia FerrarettiMaria Cristina Magli
May 24, 2007·International Journal of Geriatric Psychiatry·Thaís Soares Cianciarullo MinettPaulo Henrique Ferreira Bertolucci
Jul 10, 2008·Human Reproduction·G PenningsP Devroey

❮ Previous
Next ❯

Citations

Nov 26, 2013·Reproductive Biomedicine Online·Luca GianaroliMaria Cristina Magli
Jan 25, 2012·Obstetrics and Gynecology International·Paul R Brezina, Yulian Zhao
Mar 30, 2010·Human Reproduction·F ShenfieldUNKNOWN ESHRE Taskforce on Cross Border Reproductive Care
Aug 15, 2013·Human Reproduction·Virginie Rozée Gomez, Elise de La Rochebrochard
Jun 12, 2013·Environmental Health and Preventive Medicine·Yuri HibinoHiroyuki Nakamura
Mar 26, 2013·Fertility and Sterility·UNKNOWN Ethics Committee of American Society for Reproductive Medicine
Oct 4, 2011·Reproductive Biomedicine Online·Eric BlythTewes Wischmann
Oct 1, 2011·Reproductive Biomedicine Online·Nicky Hudson, Lorraine Culley
Apr 19, 2011·Reproductive Biomedicine Online·Nicky HudsonAllan Pacey
May 7, 2014·Clinical Genetics·V CoutureC Bouffard
Mar 27, 2013·Human Fertility : Journal of the British Fertility Society·Jennifer Hunt
Mar 31, 2015·Reproductive Biomedicine Online·Pim M W JanssensJackson C Kirkman-Brown
May 25, 2011·Biochimica Et Biophysica Acta·Yulian ZhaoEdward Wallach
Aug 24, 2012·Israel Journal of Health Policy Research·Carmel Shalev, Gabriele Werner-Felmayer
Jul 6, 2016·Reproductive Biomedicine Online·Vittorio LingiardiRoberto Baiocco
Sep 30, 2016·Fertility and Sterility·UNKNOWN Ethics Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, UNKNOWN Ethics Committee of the American Society for Reproductive Medicine
Dec 12, 2018·Human Fertility : Journal of the British Fertility Society·Vasanti JadvaNatalie Gamble
Jul 4, 2019·The Hastings Center Report·Achim RosemannNick Lee
Nov 2, 2019·Journal of Assisted Reproduction and Genetics·Daphna Birenbaum-Carmeli, Piero Montebruno
Mar 1, 2012·Current Opinion in Obstetrics & Gynecology·Marcia C Inhorn, Pasquale Patrizio
Dec 5, 2017·Global Health Research and Policy·Anastasia Paraskou, Babu P George
Jul 28, 2016·BMC Women's Health·Irene RiezzoEmanuela Turillazzi
May 29, 2018·Journal of Assisted Reproduction and Genetics·Mahmoud SalamaPasquale Patrizio
Jan 3, 2021·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Paola FratiVittorio Fineschi
Jan 7, 2021·Journal of Medical Ethics·Alex Polyakov, Genia Rozen
Oct 20, 2021·Journal of Religion and Health·Ya'arit Bokek-CohenMahdi Tarabeih

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.